Cystic Fibrosis Treatment Report

www.CysticFibrosisTreatmentReport.com

PTI-801

Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis

https://clinicaltrials.gov/ct2/show/NCT03140527?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=08%2F26%2F2019&lupd_d=14

Conditions :   Healthy Volunteer;   Cystic Fibrosis

Interventions :   Drug: PTI-801;   Drug: Placebo;   Drug: PTI-808

Sponsor :   Proteostasis Therapeutics, Inc.

Recruiting

Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis

NCT03140527

Thu, 04 May 2017 12:00:00 EDT

Last Update Posted: 09/09/19 10:07AM

Back to top